Health Digest
2 weeks ago
Sorfequiline: A Game - Changer for TB Treatment?
Sorfequiline shows stronger action than existing treatments against illness that killed 1.
Sorfequiline: A Game - Changer for TB Treatment?
A promising new drug, sorfequiline, could significantly enhance tuberculosis (TB) treatment, according to recent trial results. This breakthrough comes as the World Health Organization (WHO) highlights TB as a "major global public-health problem" and the leading infectious cause of death, with 1.23 million deaths reported last year alone. The trial, conducted by the TB Alliance across multiple countries including South Africa, the Philippines, Georgia, Tanzania, and Uganda, involved 309 participants who showed stronger efficacy against drug-resistant TB compared to existing treatments.
The new antibiotic demonstrated a comparable safety profile to current drugs but outperformed them in clinical trials, particularly in reducing the time needed for effective treatment. This could mean shorter TB treatment durations, potentially cutting months off the typical six-month regimen. Dr. Maria Beumont, vice-president of the TB Alliance, emphasized the flexibility this offers, allowing immediate treatment without the need for extensive diagnostic delays.
Despite these encouraging results, challenges remain. Access to swift and accurate TB diagnostics is still limited in many regions, often taking days or weeks for laboratories to confirm the type of TB a patient has.
This delay can hinder timely and effective treatment.
The WHO warns that progress towards ending TB as a public-health threat by 2030 is jeopardized by ongoing aid cuts and falling short of global targets. Sorfequiline's potential to streamline diagnosis and treatment could be a crucial step in addressing these issues and improving outcomes for TB patients worldwide.